EPHA2 and prostate cancer: In addition, the SAM domain can control the function of the neighbouring kinase domain, since its removal from EphA2 increased tyrosine autophosphorylation in human prostate cancer cells and in a mouse skin carcinoma cell line, resulting in constitutive activity [9].